MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $8.75 (58.80% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetActions
5/1/2015William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015StephensInitiated CoverageEqual Weight$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Maxim GroupBoost Price TargetBuy$10.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014Deutsche BankUpgradeNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2013Maxim GroupBoost Price TargetBuy$4.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2013 forward)